Friday 6 November 2026 Export HAE’s income statement to Excel — free account

Haemonetics Corporation

Haemonetics Corporation’s revenue for fiscal 2026 (year ended March 2026) was $1.3 billion, down 1.97% from fiscal 2025.

Revenue: +9.30%
EPS: +25.9%
Free cash flow: +20.4%
Total debt: +21.0%

Quarter to September 2026, against a year earlier

120.06 4.05 −3.26%

Follow HAE

Alert me

Market cap: $5.7B
P/E: 54.5×
Fwd P/E: 30.2×
Dividend yield: —
F-score: 6/9
Altman Z: 2.21
Beneish M: −2.81
Dividend safety: n/a

Overview

Haemonetics Corporation (HAE) P/E ratio

Alert me on P/E ratio

As of 5 November 2026, Haemonetics Corporation (HAE) trades at a P/E ratio of 54.5×. Over the past ten years it has ranged from 0.0× (March 2018) to 737× (November 2017); the current reading is higher than 56% of that period. That is above the Medical Devices industry median of 25.6× and above the Healthcare sector median of 25.2×.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/HAE/pe-ratio" width="100%" height="360" style="border:0" loading="lazy" title="Haemonetics Corporation P/E ratio, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/HAE/metrics/pe-ratio">Haemonetics Corporation (HAE) P/E ratio — stockrow.com</a></p>

Period	P/E ratio	Change
FY2026	27.8×	45.92%
FY2025	19.0×	(48.61%)
FY2024	37.0×	0.68%
FY2023	36.8×	(51.13%)
FY2022	75.3×	5.76%
FY2021	71.2×	7.82%
FY2020	66.0×	(22.79%)
FY2019	85.5×	1.87%
FY2018	83.9×	—
FY2017	0.0×	—

Period	P/E ratio	Change
Sep 2026	46.6×	27.35%
Jun 2026	36.6×	31.78%
Mar 2026	27.8×	26.43%
Dec 2025	22.0×	54.98%
43 more quarters	Free account

Against its own ten years

Low 0.0× High 737×

Ten-year median 48.7×

Current reading's percentile 55

Company	P/E ratio
BRKR Bruker Corporation compare	n/m
AXGN AxoGen, Inc. compare	n/m
IRTC iRhythm Holdings, Inc. compare	n/m
TXG 10x Genomics compare	n/m
BIO Bio-Rad Laboratories, Inc. compare	9.7×
BIO.B Bio-Rad Laboratories, Inc. compare	9.9×
LIVN LivaNova PLC compare	25.6×
ITGR Integer Holdings Corporation compare	42.2×
HAE Haemonetics Corporation	54.5×
Medical Devices industry median	25.6×
Healthcare sector median	25.2×
Market median	17.9×

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

Haemonetics Corporation (HAE) P/E ratio

P/E ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/E ratio against peers

What P/E ratio is

More on HAE

P/E ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/E ratio against peers

What P/E ratio is

More on HAE

Stockrow Weekly